liorate impaired motor function of APPswe and APPswe/PS1 E9 transgenic mice. Soc Neurosci Abstr 31:586.3.
Blass JP (2000) The mitochondrial spiral. An adequate cause of dementia in
the Alzheimer's syndrome. Ann NY Acad Sci 924:170 –183.
Boncristiano S, Calhoun ME, Kelly PH, Pfeifer M, Bondolfi L, Stalder M,
Phinney AL, Abramowski D, Sturchler-Pierrat C, Enz A, Sommer B,
Staufenbiel M, Jucker M (2002) Cholinergic changes in the APP23
transgenic mouse model of cerebral amyloidosis. J Neurosci
22:3234 –3243.
Borchelt DR, Thinakaran G, Eckman CB, Lee MK, Davenport F, Ratovitsky T,
Prada CM, Kim G, Seekins S, Yager D, Slunt HH, Wang R, Seeger M,
Levey AI, Gandy SE, Copeland NG, Jenkins NA, Price DL, Younkin SG,
Sisodia SS (1996a) Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1– 42/1– 40 ratio in vitro and in vivo. Neuron
17:1005–1013.
Borchelt DR, Davis J, Fischer M, Lee MK, Slunt HH, Ratovitsky T, Regard J,
Copeland NG, Jenkins NA, Sisodia SS, Price DL (1996b) A vector for
expressing foreign genes in the brains and hearts of transgenic mice.
Genet Anal 13:159 –163.
Borchelt DR, Ratovitski T, van Lare J, Lee MK, Gonzales V, Jenkins NA,
Copeland NG, Price DL, Sisodia SS (1997) Accelerated amyloid deposition in the brains of transgenic mice coexpressing mutant presenilin 1 and
amyloid precursor proteins. Neuron 19:939 –945.
Braak H, Braak E (1990) Alzheimer's disease: striatal amyloid deposits and
neurofibrillary changes. J Neuropathol Exp Neurol 49:215–224.
Braak H, Braak E (1991) Neuropathological stageing of Alzheimer-related
changes. Acta Neuropathol 82:239 –259.
Brendza RP, O'Brien C, Simmons K, McKeel DW, Bales KR, Paul SM, Olney
JW, Sanes JR, Holtzman DM (2003) PDAPP; YFP double transgenic
mice: a tool to study amyloid-beta associated changes in axonal, dendritic,
and synaptic structures. J Comp Neurol 456:375–383.
Brendza RP, Bacskai BJ, Cirrito JR, Simmons KA, Skoch JM, Klunk WE,
Mathis CA, Bales KR, Paul SM, Hyman BT, Holtzman DM (2005) AntiAbeta antibody treatment promotes the rapid recovery of amyloidassociated neuritic dystrophy in PDAPP transgenic mice. J Clin Invest
115:428 – 433.
Brilliant MJ, Elble RJ, Ghobrial M, Struble RG (1997) The distribution of
amyloid beta protein deposition in the corpus striatum of patients with
Alzheimer's disease. Neuropathol Appl Neurobiol 23:322–325
Burns JM, Galvin JE, Roe CM, Morris JC, McKeel DW (2005) The pathology of the substantia nigra in Alzheimer disease with extrapyramidal
signs. Neurology 64:1397–1403.
Castellani R, Hirai K, Aliev G, Drew KL, Nunomura A, Takeda A, Cash AD,
Obrenovich ME, Perry G, Smith MA (2002) Role of mitochondrial dysfunction in Alzheimer's disease. J Neurosci Res 70:357–360.
Cataldo AM, Peterhoff CM, Troncoso JC, Gomez-Isla T, Hyman BT, Nixon
RA (2000) Endocytic pathway abnormalities precede amyloid beta deposition in sporadic Alzheimer's disease and Down syndrome: differential
effects of APOE genotype and presenilin mutations. Am J Pathol
157:277–286.
Cataldo AM, Peterhoff CM, Schmidt SD, Terio NB, Duff K, Beard M,
Mathews PM, Nixon RA (2004) Presenilin mutations in familial Alzheimer disease and transgenic mouse models accelerate neuronal lysosomal
pathology. J Neuropathol Exp Neurol 63:821– 830.
Diez M, Koistinaho J, Kahn K, Games D, Hokfelt T (2000) Neuropeptides in
hippocampus and cortex in transgenic mice overexpressing V717F betaamyloid precursor protein—initial observations. Neuroscience
100:259 –286.
Ditter SM, Mirra SS (1987) Neuropathologic and clinical features of Parkinson's disease in Alzheimer's disease patients. Neurology 37:754 –760.
Gajdusek DC (1985) Hypothesis: interference with axonal transport of neurofilament as a common pathogenetic mechanism in certain diseases of
the central nervous system. N Engl J Med 312:714 –719.
Gearing M, Levey AI, Mirra SS (1997) Diffuse plaques in the striatum in
Alzheimer disease (AD): relationship to the striatal mosaic and selected
neuropeptide markers. J Neuropathol Exp Neurol 56:1363–1370.
German DC, Yazdani U, Speciale SG, Pasbakhsh P, Games D, Liang CL
(2003) Cholinergic neuropathology in a mouse model of Alzheimer's
disease. J Comp Neurol 462:371–381.
Gibb WR, Mountjoy CQ, Mann DM, Lees AJ (1989) The substantia nigra
and ventral tegmental area in Alzheimer's disease and Down's syndrome.
J Neurol Neurosurg Psychiatry 52:193–200.
